Assetmark Inc. Boosts Stake in Veeva Systems

The institutional investor increased its holdings in the cloud software company by 21% in the fourth quarter.

Apr. 16, 2026 at 7:20am

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of financial reports, a laptop, and a desk lamp on a clean, monochromatic background, symbolizing the abstract concepts of corporate strategy, finance, and technology innovation in the life sciences industry.Veeva Systems' cloud-based software solutions continue to attract institutional investors seeking exposure to the growing life sciences technology market.Pleasanton Today

Assetmark Inc. has increased its stake in Veeva Systems Inc. (NYSE:VEEV) by 21.0% in the fourth quarter, according to a recent filing with the Securities & Exchange Commission. The institutional investor now owns 131,041 shares of the technology company's stock, worth approximately $29.25 million.

Why it matters

Veeva Systems is a leading provider of cloud-based software solutions for the global life sciences industry. The increase in Assetmark's holdings suggests continued investor confidence in the company's growth prospects and market position.

The details

Assetmark Inc. purchased an additional 22,747 shares of Veeva Systems in the fourth quarter, bringing its total stake to 131,041 shares. This represents approximately 0.08% of the technology company's outstanding shares. Veeva Systems provides a range of industry-specific applications and data solutions for pharmaceutical, biotechnology, medical device, and consumer health companies.

  • Assetmark Inc. increased its Veeva Systems holdings in the fourth quarter of 2025.
  • Veeva Systems completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

The players

Assetmark Inc.

An institutional investor that manages assets for individual and institutional clients.

Veeva Systems Inc.

A cloud software company that develops industry-specific applications and data solutions for the global life sciences sector.

Got photos? Submit your photos here. ›

The takeaway

Assetmark's increased stake in Veeva Systems reflects the continued investor confidence in the company's growth potential within the life sciences software market. As Veeva Systems expands its product offerings and international presence, its cloud-based solutions remain in high demand among pharmaceutical, biotech, and medical device companies.